Description
A decrease in the activity of the ADAMTS-13 enzyme leads to the development of thrombotic thrombocytopenic purpura - a rare life-threatening disease characterized by non-immune microangiopathic hemolytic anemia, thrombocytopenia, petechiae, hematomas, and hyperbilirubinemia. A functional defect in ADAMTS13 can be caused either by pathogenic variants in the gene or by autoantibody inhibitors of ADAMTS-13.
Period of execution
Within 10 days. The specified time does not include the day of biomaterial collection
Biomaterial type